Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes

BACKGROUND: The lower-risk (low and intermediate-1 risk based on IPSS) myelodysplastic syndrome (MDS) has a negative impact on patients’ health-related quality of life (HRQoL). Patient Reported Outcomes (PROs) instruments, which are used to collect patients’ HRQoL data, should have established conte...

Descripción completa

Detalles Bibliográficos
Autores principales: Trudeau, Jeremiah J., He, Jianming, Rose, Esther, Panter, Charlotte, Randhawa, Sharan, Gater, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450032/
https://www.ncbi.nlm.nih.gov/pubmed/32851569
http://dx.doi.org/10.1186/s41687-020-00235-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450032/
https://www.ncbi.nlm.nih.gov/pubmed/32851569
http://dx.doi.org/10.1186/s41687-020-00235-4

Ejemplares similares